160 related articles for article (PubMed ID: 31852014)
1. Health-related quality of life in Waldenstrom Macroglobulinemia and IgM-related disorders: A single institution experience.
Frustaci AM; Nichelatti M; Deodato M; Zamprogna G; Minga P; Pioltelli ML; Cairoli R; Tedeschi A
Hematol Oncol; 2020 Feb; 38(1):111-113. PubMed ID: 31852014
[No Abstract] [Full Text] [Related]
2. [Significance of monoclonal macroglobulinemia].
Leporrier M
Rev Prat; 1993 Feb; 43(3):298-301. PubMed ID: 8502959
[TBL] [Abstract][Full Text] [Related]
3. Waldenström macroglobulinemia treatment algorithm 2018.
Gertz MA
Blood Cancer J; 2018 May; 8(4):40. PubMed ID: 29712895
[TBL] [Abstract][Full Text] [Related]
4. Clinical characteristics and factors predicting evolution of asymptomatic IgM monoclonal gammopathies and IgM-related disorders.
Morra E; Cesana C; Klersy C; Barbarano L; Varettoni M; Cavanna L; Canesi B; Tresoldi E; Miqueleiz S; Bernuzzi P; Nosari AM; Lazzarino M
Leukemia; 2004 Sep; 18(9):1512-7. PubMed ID: 15322559
[TBL] [Abstract][Full Text] [Related]
5. Secondary malignancies in patients with multiple myeloma, Waldenström macroglobulinemia and monoclonal gammopathy of undetermined significance.
Castillo JJ; Gertz MA
Leuk Lymphoma; 2017 Apr; 58(4):773-780. PubMed ID: 27546465
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic framing of IgM monoclonal gammopathy: Focus on Waldenström macroglobulinemia.
Tedeschi A; Conticello C; Rizzi R; Benevolo G; Laurenti L; Petrucci MT; Zaja F; Varettoni M
Hematol Oncol; 2019 Apr; 37(2):117-128. PubMed ID: 30192023
[TBL] [Abstract][Full Text] [Related]
7. Peripheral neuropathies associated with monoclonal proteins: a clinical review.
Kelly JJ
Muscle Nerve; 1985 Feb; 8(2):138-50. PubMed ID: 2997604
[TBL] [Abstract][Full Text] [Related]
8. Antibody activity of monoclonal immunoglobulins in myeloma, macroglobulinemia and benign gammapathy.
Waldenström JG
Med Oncol Tumor Pharmacother; 1986; 3(3-4):135-40. PubMed ID: 3100882
[No Abstract] [Full Text] [Related]
9. IgM monoclonal gammopathy of undetermined significance (MGUS) and smoldering Waldenström's macroglobulinemia (SWM).
Kyle RA; Dispenzieri A; Kumar S; Larson D; Therneau T; Rajkumar SV
Clin Lymphoma Myeloma Leuk; 2011 Feb; 11(1):74-6. PubMed ID: 21454195
[TBL] [Abstract][Full Text] [Related]
10. [Subsets of T cells in myeloma, macroglobulinemia and benign monoclonal gammopathy: analysis of surface markers defined by monoclonal antibodies and the effect on Ig-synthesis by B cells].
Okagawa K; Iguchi K; Iishi Y; Kosaka M
Nihon Ketsueki Gakkai Zasshi; 1985 Aug; 48(5):1205-13. PubMed ID: 3934898
[No Abstract] [Full Text] [Related]
11. Paraproteinemic neuropathies.
Vital A
Brain Pathol; 2001 Oct; 11(4):399-407. PubMed ID: 11556684
[TBL] [Abstract][Full Text] [Related]
12. Neuropathies and paraproteins.
Lunn MP
Curr Opin Neurol; 2019 Oct; 32(5):658-665. PubMed ID: 31313705
[TBL] [Abstract][Full Text] [Related]
13. Characteristics and Prognosis of Patients with Immunoglobulin M Monoclonal Gammopathy.
Tanaka H; Sakuma Y; Ikeda H; Shimizu R; Sugita Y; Iwai R
J Clin Exp Hematop; 2017; 57(2):47-53. PubMed ID: 29021514
[TBL] [Abstract][Full Text] [Related]
14. Clinical Presentation and Gene Expression Profiling of Immunoglobulin M Multiple Myeloma Compared With Other Myeloma Subtypes and Waldenström Macroglobulinemia.
Atrash S; Zhang Q; Papanikolaou X; Stein C; Abdallah AO; Barlogie B
J Glob Oncol; 2018 Sep; 4():1-8. PubMed ID: 30241189
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal gammopathy of undetermined significance and Waldenström's macroglobulinemia.
Mailankody S; Landgren O
Best Pract Res Clin Haematol; 2016 Jun; 29(2):187-193. PubMed ID: 27825465
[TBL] [Abstract][Full Text] [Related]
16. When a Monoclonal Gammopathy Is Not Multiple Myeloma.
Derman B; Castillo JJ; Sarosiek S; Beksac M
Am Soc Clin Oncol Educ Book; 2022 Apr; 42():1-10. PubMed ID: 35394823
[TBL] [Abstract][Full Text] [Related]
17. [Neurological manifestations of monoclonal gammopathies].
Chassande B; Léger JM
Rev Prat; 1993 Feb; 43(3):314-6. PubMed ID: 8389055
[TBL] [Abstract][Full Text] [Related]
18. The spectrum of IgM monoclonal gammopathy in 430 cases.
Kyle RA; Garton JP
Mayo Clin Proc; 1987 Aug; 62(8):719-31. PubMed ID: 3110508
[TBL] [Abstract][Full Text] [Related]
19. Factors predicting transformation of asymptomatic IgM monoclonal gammopathy.
Greco A; Tedeschi A; Varettoni M; Nichelatti M; Paris L; Ricci F; Vismara E; Morra E
Clin Lymphoma Myeloma Leuk; 2011 Feb; 11(1):77-9. PubMed ID: 21454196
[TBL] [Abstract][Full Text] [Related]
20. Investigation and Management of Immunoglobulin M- and Waldenström-Associated Peripheral Neuropathies.
Tomkins O; Leblond V; Lunn MP; Viala K; Weil DR; D'Sa S
Hematol Oncol Clin North Am; 2023 Aug; 37(4):761-776. PubMed ID: 37385714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
